My Life

Hi, I’m a PhD scientist at the California Institute of Technology (commonly known as Caltech). My official title there is ‘Postdoctoral Research Scholar’ in the biology division.

I come from a family where a lot of people are obese (mostly on my mother’s side). Growing up in elementary, middle school, and high school I was the fat kid of my school. In high school I started getting active in sports; but it wasn’t until college where I really got fit. My first quarter of college I joined the club rowing team and lost 50 pounds in 11 weeks. The next quarter I joined the varsity team as a lightweight rower and trained extensively until my senior year. Since then I’ve still rowed but restarted emphasizing weight training and different types of cross training (martial arts, running, etc.). Leading up to my wedding I gained about 15 pounds and didn’t really notice until after the honeymoon. That is what got me into monitoring what I am eating and my physical activity. In the past year I have lost about 10 lbs, mostly due to marathon training.

Since then I’ve spent most of my time doing Beachbody workouts (P90X and Insanity). In the past few months I’ve been able to drop my body fat from 22% to ~8%. I’ve seen so much success teaming up Beachbody workouts and nutrition with Fatsecret that I’m definitely going to keep working hard to improve my health.

Feel free to check out my websites:
Brandon’s Coach Page
Shakeology Page

CURRICULUM VITAE

Brandon Jarrod Henderson, Ph.D.

 Office                                                                                                             

California Institute of Technology                                                                                          Phone: (614) 330-1463

1200 E. California Blvd, MC 156-29, Pasadena, CA 91125

Email: bhenders@caltech.edu

Education

Undergraduate: The Ohio State University, Columbus, OH, 2002-2006. B.S. with distinction, Chemistry.

Graduate:         The Ohio State University, Columbus, OH, 2006-2011. Ph.D., Pharmacology.

Postdoctoral:     California Institute of Technology, Pasadena, CA. December 2011-Present.

Research Experience

  • 2011-Current. National Collaborative Drug Discovery and Development Group (NCDDDG)

The NCDDDG group is a collaborative effort among a subgroup of Henry Lester’s lab at the California Institute of Technology (Pasadena, CA), Michael Mark’s group at the University of Colorado (Boulder, CO) and a drug company, Targacept (Winston Salem, NC). This group utilizes a multitude of scientific disciplines in the effort to design drugs that specifically target α6* and α4* nAChRs as potential treatment strategies for nicotine addiction and Parkinson’s disease.

  • 2011-Current. Postdoctoral Research Fellow. Sponsor, Henry A. Lester, California Institute of Technology, Division of Biology.

My current project focuses on characterizing how menthol in cigarettes may exacerbate addiction to nicotine.

  • 2006-2011. Graduate Research. Advisor, Dennis B. McKay, The Ohio State University, Division of Pharmacology, College of Pharmacy.

Project focused on the discovery of novel therapeutic molecules for the treatment of nicotine addiction by employing a multidisciplinary approach including: pharmacology, molecular biology, computational chemistry, and chemistry.

  • 2007-2011. Nicotinic Receptor Drug Discovery Group (NRDDG).

The NRDDG was a collaborative effort amount pharmacologists and chemists to identify novel noncompetitive antagonists for nicotine cessation. This included the laboratories of Dennis McKay, Rob Coleman, Chenglong Li, Karl Werbovetz (The Ohio State University) and Steve Bergmeier (Ohio University).

  • 2004-2006. Analytical Chemist.  M.A.R.C Laboratory, Columbus Ohio. Supervisor, John O. Olesik.

Responsible for quantifying trace level substances using two forms of inductively coupled plasma (ICP) instruments: 1) mass spectrometer (ICP-MS) and 2) optical emission spectrometer (ICP-OES).

  • 2004-2006. Undergraduate Research.  Advisor, John O. Olesik, the Ohio State University, department of Chemistry, College of Math and Physical Sciences.

Studied and catalogued the reactions of Ion-Molecule chemistry using a Dynamic Reaction Cell Mass Spectrometer (ICP-DRC-MS).  Studies were completed using many forms of reaction gasses: methane, nitrogen, ammonia, and oxygen.  Additional work focused on reducing molecular overlaps that are common with plasma spectrometers as well as interferences that arise from matrix effects.

Current Funding

1 K99DA04047 (Henderson, PI)             03/01/2016-02/28/2021                                      NIH/NIDA

Characterization of Menthol’s effect on nicotine reinforcement and nicotinic receptor neurobiology

 

Peer Reviewed Publications

  1. Henderson, B.J.; Wall, T.; Henley, B.M.; Kim, C.H.; Nichols, W.A.; Xiao, C.; and Lester, H.A. Menthol alone upregulates midbrain nAChRs, alters nAChR subtype stoichiometry, alters dopamine neuron firing frequency, and prevents nicotine reward. J Neurosci. 36, 2957-2974. DOI: 10.1523/JNEUROSCI.4194-15.2016

  1. Srinivasan, R.; Henley, B.M.; Henderson, B.J.; Indersmitten, T.; Mckinney, S.; Deshpande, P.; Xiao, C.; and Lester, H.A. (2016) Smoking-relevant nicotine concentration inhibits the unfolded protein response in dopaminergic neurons. J Neurosci. 36, 69-75. DOI: 10.1523/JNEUROSCI.2126-15.2016

  1. Henderson, B.J. and Lester, H.A. (2015) Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology. 96 Part B, 178-193. DOI:10.1016/j.neuropharm.2015.01.022.

  1. Xiao, C.; Miwa, J.M.; Henderson, B.J.; Wang, Y.; Deshpande, P.; McKinney, S.L.; Lester, H.A. (2015) Nicotinic receptor subtypes within selective circuits of the subthalamic nucleus. J Neurosci. 35, 3734-3746. DOI: 10.1523/JNEUROSCI.3528-14.2015. Featured Article

  1. Nichols, W.A.; Henderson, B.J.; Yu, C.Y.; Parker, R.L.; Richards, C.I.; Lester, H.A.; and Miwa, J.M. (2014) Lynx1 shifts α4β2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum. J Biol Chem. 289, 31423-31432. DOI:10.1074/jbc.M114.573667

  1. Srinivasan, R.; Henderson, B.J.; Lester, H.A.; and Richards, C.I. (2014) Pharmacological chaperoning of nAChRs: a new therapeutic target for Parkinson’s disease. Pharmacol Res. 83, 20-29. DOI: 10.1016/j.phrs.2014.02.005

  1. Henderson, B.J.; Srinivasan, R.; Nichols, W.N.; Dilworth, C.; Gutierrez, D.F.; McKinney, S.; Mackey, E.D.W.; Drenan, R.M.; Richards, C.I.; and Lester, H.A. (2014) Nicotine exploits a COPI-mediated process for chaperone-mediated upregulation of its receptors. J Gen Physiol. 143, 51-56. Cover Article

  1. Yi, B.; Long, S., González-Cestari, T.F.; Henderson, B.J., Pavlovicz, R.E., Werbovetz, K., Li, C., and McKay, D.B. (2013) Discovery of Benzamide Analogs as Negative Allosteric Modulators of Human Neuronal Nicotinic Receptors: Pharmacophore Modeling, Rational Design, and Structure-Activity Relationship Studies. Bioorg Med Chem 21, 4730-4743.

  1. Henderson, B.J.; González-Cestari, T.F.; Yi, B.; Pavlovicz, R.E.; Boyd, R.T.; Li, C.; Bergmeier, S.C., and McKay, D.B.  (2012) Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human α4β2 Neuronal Nicotinic Receptors. ACS Chem Neurosci 3, 682-692.

  1. Henderson, B.J.; Orac, C.M.; Maciagiewicz, I; Bergmeier, S.B.; and McKay D.B. (2012) QSAR and QSSR models of negative allosteric modulators targeting nicotinic acetylcholine receptors facilitate the design of a novel selective antagonist of nicotinic acetylcholine receptors. Bioorg Med Chem Lett 22, 1797-1813.

 

  1. Henderson, B.J.; Carper, D.J.; González-Cestari, T.F.; Yi B.; Dalefield, M.L.; Coleman, R.S.; McKay, D.B. (2012) Synthesis and Structure activity relationship studies of novel piperazine analogs as novel negative allosteric modulators of neuronal nicotinic receptors. J Med Chem 54, 8681-8692.

  1. Still P.C., González-Cestari, T.F., Pan, L., Chai, H., Fuchs, J.R, Ngoc Ninh, T., Soejarto, D.D., Yi, B., Henderson, B.J., McKay, D.B., Kinghorn, A.D. (2012) Alkaloids from Grewia Paniculata with cytotoxic and non-competitive nicotinic receptor antagonistic activities. Planta Med 78, CL11. DOI: 10.1055/s-0032-1320246

  1. Mahasenan, K.V.; Pavlovicz, R.E.; Henderson, B.J.; González-Cestari, T.F.; Yi B.; McKay, D.B.; and Li, C. (2011) Discovery of novel α4β2 neuronal nicotinic receptor modulators through structure-based virtual screening. ACS Med Chem Lett 2, 855-860.

  1. Pavlovicz, R.E.; Henderson, B.J.; Bonnell, A.B.; Boyd, R.T.; and McKay, D.B.; Li, C. (2011) Identification of a novel negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptors. PLoS ONE 6(9): e24949. doi:10.1371/journal.pone.0024949

  1. Henderson, B.J.; Pavlovicz, R.E.; Allen, J.A.; González-Cestari, T.F.; Orac, C.M.; Bonnell, A.B.; Zhu, M.X.; Boyd, R.T.; Li, C.; Bergmeier, S.C., and McKay, D.B. (2010) Negative allosteric modulators that target human α4β2 neuronal nicotinic receptors. J Pharmacol Exp Therap 334, 761-774. Cover Article

  1. González-Cestari, T.F.; Henderson, B.J.; Pavlovicz, R.E. McKay; S.B., El-Hajj, R.A.; Pulipaka, A,B.; Orac, C.M.; Reed, D.D.; Boyd, R.T.; Zhu, M.X.; Li, C.; Bergmeier, S.C.; and McKay, D.B. (2009) Effect of novel negative allosteric modulators of neuronal nicotinic receptors on cells expressing native and recombinant nicotinic receptors: Implications for drug discovery. J Pharmacol Exp Therap 328, 504-515

  1. Henderson, B.J. and Olesik, J.W. (2006) Use of Ion Molecule Reactions in Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to Improve Selenium Analysis and Detection. Knowledge Bank, http://hdl.handle.net/1811/6574

Publications (In Review)

  1. Nichols, W.A.; Henderson, B.J.; Yu, C.Y.; Marotta, C.B.; Richards, C.I.; Dougherty, D.A.; Cohen, B.N.; and Lester, H.A. Suppression of low-sensitivity α4β2 nicotinic receptor expression by a mutation linked to autosomal dominant nocturnal frontal lobe epilepsy. PLoS ONE.

  1. Wall, T.R.; Voren, G.; Henderson, B.J.; Wageman, C.R.; Deshpande, P.; Cohen, B.N.; Grady, S.R.; Marks, M.J.; Yohannes, D.; Bencherif, M.; Kenny, P.J.; and Lester, H.A. A Novel Nicotinic Agonist is Selective for α6β2*-nAChRs at Low Doses and Potentiates Nicotine Self-Administration. Neuropharmacology.

 

Press Releases

  1. 2014. New Scientist. Menthol increases nicotine addiction by tweaking brain. http://www.newscientist.com/article/dn26668-menthol-increases-nicotine-addiction-by-tweaking-brain.html#.VIeHBDHF98G
  2. 2014. Rockefeller University Press. Nicotine exploits COPI to foster addiction. http://www.eurekalert.org/pub_releases/2013-12/rup-nec121913.php

Commentaries

Anand, R. COPI polices nicotine-mediated up-regulation of nicotinic receptors. J Gen Physiol. 143, 49-50.

Patents

  1. Lester, H.A.; Srinivasan, R.; Richards, C.I.; and Henderson, B.J. (2013) Neuroprotection by pharmacological chaperoning of nicotinic acetylcholine receptors. US Patent Application 13/752,288. Publication number: US20130197023 A1

Awards, Honors and Recognitions

  • NIH K99/R00 Pathways to Independence Grant Recipient (2016-present; K99DA040047)
  • Best Talk. Translational Nicotine Research Group Symposium. UCLA, 2015
  • NIDA Young Investigator Travel Award, 2015
  • Best Talk. 9th Annual DIDARP Drug Abuse Research day, 2014
  • Best Poster, 2014 Wellcome Trust Conference on Nicotinic Acetylcholine Receptors, Cambridge, UK
  • NIDA NRSA (F32) Postdoctoral Fellow (2012-2015; F32DA033721)
  • TRDRP Postdoctoral Fellowship Award, 2012

(Awarded; but deferred in favor of awarded NRSA)

  • NIDA Minority Postdoctoral Fellowship, 2012

(Awarded; but deferred in favor of awarded NRSA)

  • NIDA Travel Award, 2010
  • NIDA Diversity Enhancement Pre-doctoral Fellowship Award, 2009-2011
  • Chauncey D. Leake Memorial Award in Pharmacology, 2010
  • Norman J. Uretsky Fellowship in Pharmacology, 2010-2011.
  • Patil Graduate Fellowship in Pharmacology, 2009-2010
  • Second Place, Poster Presentation, College of Pharmacy Research Day, The Ohio State University, May 2009.
  • Third Place, Denman Undergraduate Research Forum, The Ohio State University, May 2006
  • National Collegiate Scholar Athlete, 2002-2004, 2006
  • National Deans’ List, 2002-2004, 2006
  • National Collegiate Honor Roll, 2002
  • Full Academic Scholarship, the Ohio State University, 2002-2006

Professional Societies and Activities

International Drug Abuse Research Society, 2012-Present

American Association for Pharmaceutical Scientists, 2010-Present

Society for Neuroscience, 2009-Present

American Chemical Society, 2004-Present

National Collegiate Honor Society, 2002-2006

Editorial Activities

2015-Present. Cellular Physiology and Biochemistry. Peer Reviewer

2014-Present. Neuropharmacology. Peer Reviewer

2012-Present. Journal of Pharmacology and Experimental Therapeutics. Peer Reviewer

2012-Present. Journal of Medicinal Chemistry. Peer Reviewer

2012-Present. European Journal of Medicinal Chemistry. Peer Reviewer

 

Press Talks

Henderson, B.J. and Lester H.A. Why smokers of menthol cigarettes may find it harder to quit: menthol’s interaction with certain brain receptors may potentiate the addiction to nicotine. Society for Neuroscience Press Conference 2014: Legal Drugs of Abuse. Washington D.C., November 2014.

Invited Speaking Engagements:

  • Menthol Enhances Nicotine Reward-related Behavior by Potentiating Nicotine-induced Changes in Midbrain Dopamine Neurons. Presented at Tobacco Control, Research, and Education: Joining Forces to Address New Challenges. Joint conference co-hosted by the Tobacco Related Disease Research Program (TRDRP), the California Tobacco Control Program (CTCP), and the Tobacco-Use Prevention Education Program (TUPE). Sacramento, CA, October 2015.
  • Maintained low-dose of menthol alters nicotine reinforcement and nicotinic receptor assembly. Presented at the Translational Nicotine Research Group Symposium. University of California Los Angeles. Los Angeles, CA, June 2015.
  • Why Smokers of Menthol Cigarettes May Find It Harder to Quit – Menthol’s interaction with certain brain receptors may potentiate the addiction to nicotine. Presented at the legal drugs of abuse press conference at the 2014 SfN Annual Meeting, Washington D.C., November, 2014.
  • “Menthol alone alters nicotinic receptor number and assembly”. 9th Annual DIDARP Drug Abuse Research Day. Charles Drew University, Willowbrook, CA, September, 2014. Awarded best talk
  • “Menthol upregulates and alters the assembly of nicotinic receptors”. Bio Lunch, A gathering for the division of biology and biological engineering (BBE). California Institute of Technology, Pasadena, CA, December 2013.
  • “Menthol upregulates and alters the assembly of nicotinic receptors”. Neuro Lunch, A gathering for the division of Neuroscience. California Institute of Technology, Pasadena, CA, November 2013.

Recent Symposia, Seminars, and Presentations

Henderson, B.J.; Wall, T.; Henley, B.; Kim, C.H.; Xiao, C.; and Lester, H.A. Menthol enhances and abolishes nicotine reward by altering nACHRs and dopamine neuron excitability. Presented at Tobacco Control, Research, and Education: Joining Forces to Address New Challenges. Joint conference co-hosted by the Tobacco Related Disease Research Program (TRDRP), the California Tobacco Control Program (CTCP), and the Tobacco-Use Prevention Education Program (TUPE). Sacramento, CA, October 2015.

Henderson, B.J.; Wall, T.; Kim, C.H.; Henley, B.; Nichols, W.A.; Xiao, C.; and Lester, H.A. Menthol alone alters receptor number and assembly of α4β2 and α6β2* neuronal nicotinic receptors. Presented at the Society for Neuroscience Annual Meeting, Washington D.C., November 2014. Featured as ‘Hot Topic’

 

Invited Talk. Henderson, B.J.; Wall, T.; Nichols, W.A.; Srinivasan, R.; Xiao, C.; Lester, H.A. Menthol alone alters the number and assembly of α4β2 and α6β2* nAChRs. Presented at the 9th Annual DIDARP Drug Abuse Research Day. Charles Drew University. Los Angeles, CA, September 2014.

Henderson, B.J.; Wall, T.; Nichols, W.A.; Srinivasan, R.; Xiao, C.; Lester, H.A. Menthol alone alters the number and assembly of α4β2 and α6β2* nAChRs. Presented at the Wellcome Trust Meeting on Nicotinic Acetylcholine Receptors, Churchill College, University of Cambridge, Cambridge, UK, July 2014.

Invited Talk. Henderson, B.J. and Lester, H.A. Menthol upregulates and alters the assembly of nicotinic receptors. Biolunch. Bio Lunch. California Institute of Technology, Pasadena, CA, December 2013.

Henderson, B.J.; Srinivasan, R.; Nichols, W.N.; Dilworth, C.; Guitierrez, D.; McKinney, S.; Mackey, E.D.W.; Drenan, R.M.; Richards, C.I.; and Lester, H.A. Nicotine exploits a COPI-mediated process for chaperone-mediated upregulation of its receptors. Presented at the Society for Neuroscience Annual Meeting, San Diego, CA, November 2013.

Wall, T.; Cohen, B.N.; Wageman, C.R.; Grady, S.R.; Marks, M.J.; Henderson, B.J.; McKinney, S.; Deshpande, P.; Yohannes, D.; and Lester, H.A. Novel nicotinic agonist TI-299423 potently elicits conditioned-place preference in wild-type mice. Presented at the Society for Neuroscience Annual Meeting, San Diego, CA, November 2013.

Nichols, W.A; Yu, C.Y.; Henderson, B.J.; Marotta, C.B.; Richards, C.I.; Cohen, B.N.; and Lester, H.A. The V287L mutation in the β2 nicotinic acetylcholine subunit alters membrane expression of α4β2 and α5α4β2. The NIH Tri-Campus Symposium in Molecular and Cellular Biology. University of Southern California, Los Angeles, CA, April, 2013.

Nichols, W.A.; Henderson, B.J.; Yu, C.Y.; Richards, C.I.; Miwa, J.M.; and Lester, H.A. Lynx1 regulates α4β2 nicotinic acetylcholine receptors via intracellular effects in the endoplasmic reticulum. Presented at the Society for Neuroscience Annual Meeting, San Diego, CA, November 2013.

Yu, C.Y.; Nichols, W.A.; Henderson, B.J.; Marotta, C.B.; Richards, C.I.; Dougherty, D.A.; Cohen, B.N.; and Lester, H.A. The V287L mutation in the β2 nicotinic acetylcholine subunit alters membrane expression of α4β2 and α5α4β2. Presented at the Society for Neuroscience Annual Meeting, San Diego, CA, November 2013.

Invited Talk. Henderson, B.J. and Lester, H.A. Menthol upregulates and alters the assembly of nicotinic receptors. Neurolunch. Neuro Lunch. California Institute of Technology, Pasadena, CA, November 2013.

 

Symposium. Henderson, B.J.; Richards, C.I.; Mackey, E.D.W.; McKinney, S.; Drenan, R.M.; and Lester, H.A.  α6-Containing Neuronal Nicotinic Acetylcholine Receptors: Effects of Chronic Nicotine Treatment and Inclusion of β3 Subunits. Presented at the Society for Neuroscience Annual Meeting, New Orleans, LA, October 2012.

Symposium. Henderson, B.J.; Pavlovicz R.E.; González-Cestari, T.F; Li, C.; Boyd, R.T.; McKay, D.B. A novel site on human α4β2 nicotinic receptors mediating negative allosterism: validation of location and binding mode for modulators. Presented at the Society for Neuroscience Annual Meeting, Washington D.C., October 2011.

 

Teaching Experience

 

Pharmacy 420. Undergraduate class presenting an overview of the basic principles underlying drug action. The Ohio State University. 2006 – 2008.

Pharmacy 481. Laboratory experience in isolation, synthesis and evaluation of pharmaceutically relevant compounds. The Ohio State University. 2006 – 2010.

Pharmacy 852, Introduction to Pharmaceutical Sciences. Given to the first year graduate students in the College of Pharmacy, the Ohio State University. Topic: Current Research Involving Nicotinic Receptors. November 2010.

Pharmacy 852, Introduction to Pharmaceutical Sciences. Given to the first year graduate students in the College of Pharmacy, the Ohio State University. Topic: Nicotinic Receptors as Novel Targets for Drug Discovery. October 2009.

Students/Scientists I Have Mentored

 

Postdoctoral Scholars

Matthew J. Mulcahy, 2016-Current (California Institute of Technology)

Suparna Patowary, 2014-Current (California Institute of Technology)

Bitna Yi, 2014-Current (Stanford University)

 

Graduate Students

Teagan Wall, AU/13-SU/15 (California State University Long Beach); Currently, Statistician

Rell Parker, AU/13-AU/15 (California State University Long Beach); Currently, DVM student as UC Davis

Derrick Diego, SU/13-SU/15 (California State University Long Beach); Currently, Chemical Engineer for IFM efector

Weston Nichols, AU/12-SU/14 (California Institute of Technology); Currently, Analyst at Balyasnyl

Crystal Dilworth, AU/13-SP/14 (California Institute of Technology); Currently, Coordinator – Caltech Quantum Information and Matter

Bitna Yi, AU/10-SU/13 (Ohio State University); Currently, postdoctoral scholar at Stanford

Undergraduate Scholars

Stephanie Huard, AU/15-Current (California Institute of Technology)

Emily Meany, SP/15-AU/16 (California Institute of Technology)

Caroline Yu, SU/13-SP/14 (California Institute of Technology); Currently, MD student at Stanford

Martin Dalefield, AU/09-AU/11 (Ohio State University), PhD student, University of Otago

Jordan Zaluski, AU/09-WI/11 (Ohio State University); Currently, PhD Chemist at Boehringer Ingelheim

Alisa Baron, SU/10-AU/10 (Ohio State University)

Alex Jaeger, SP/09-SP/10 (Ohio State University); Currently, postdoctoral scholar at Duke Univ.

Omar Alkhatib, AU/08-SU/10 (Ohio State University); Currently, MD student at Ohio State Univ.

Jerad Allen, SU/08-SP/09 (Ohio State University); Currently, resident MD, Lexington, KY

Chun-Ruey Chen, WI/08-AU/09 (Ohio State University)

Amanda Amornyard, SP/07-SP/08 (Ohio State University); Currently, pharmacist at Walgreens

 

Extracurricular Activities and Awards

Trialist, 2016 Rio Olympics, Rowing – Mens Lightweight Double Sculls (LM2X)

Organizer, Veritas Forum, California Institute of Technology, 2015, 2016

1st USRowing West Coast Fall Speed Order, Lightweight Men’s Single, 2015

1st Men’s Intermediate Lightweight Double, USRowing Club National Championships, 2014

2nd Men’s Intermediate Quad, USRowing Club National Championships, 2014

2nd Men’s Senior Lightweight Double, USRowing Club National Championships, 2014

3rd Men’s Senior Quad, USRowing Club National Championships, 2014

3rd Men’s Senior Lightweight Quad, USRowing Club National Championships, 2014

3rd Men’s Senior Quad, USRowing Club National Championships, 2014

Pastor, House Church Development, Vineyard Church of Pasadena. 2014-Present

Core Team Leader, Caltech Graduate Christian Fellowship. Pasadena, CA. 2014-Current

2nd Men’s Quad, USRowing Club National Championships, 2013

3rd Men’s Lightweight Double, USRowing Club National Championships, 2013

Elite Athlete, Southern California Scullers Club, Huntington Beach, CA. 2013-Present.

Board Member, Oasis Church, Pasadena, CA. 2013-2014

Prayer Ministry Coordinator, Oasis Church, Pasadena, CA. 2012-2014.

Group Leader, Oasis Church, Pasadena, CA. 2012-2014.

Shodan (Black Belt) Shotokan karate, 2009

Group Leader, Vineyard Church of Columbus, 2007-2011.

Assistant Coach, Freshman Women’s Club Rowing Team, The Ohio State University, 2006-2007

Coaches Cup Award, Men’s Rowing, 2006

Team record (lightweight men), 20 minute ergometer test, The Ohio State University Men’s Rowing Team, 2006-current

Team record (lightweight men), 6K ergometer test, The Ohio State University Men’s Rowing Team, 2006-current

Officer (Secretary) for The Ohio State University Men’s Rowing Team, 2005-2006

Co-captain of The Ohio State University Men’s Rowing Team, 2005-2006

Scarlet and Grey Award for Men’s Rowing, 2005-2006

2nd Place. Lightweight Eight, Dad Vail National Championships of Rowing, 2005

Shodan (Black Belt) Shito-Ryu karate, 2002

 

References

Leave a Reply

Your email address will not be published. Required fields are marked *